We show that TGM2 is induced by HIF1A in prostatic lesions, correlates with HIF1A signaling in mice and humans, and is a biomarker for early relapse in patients with PCa who had undergone radical prostatectomy. This evidence concerns the gene TGM2 and posterior cortical atrophy.